were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which
104.79 1.35 1.3% Total expenses 3,066.16 2,946.38 119.78 4.1% Earning before interest and tax 341.41 279.67 61.74 22.1% Finance cost -4.83 -8.02 3.19 -39.8% Share of profit from investment in associate
13.06% Loss on exchange rate 31 126 -95 -75.43% Expected credit losses (reversal) -10 -15 5 -31.23% EBIT before share of profit (loss) from investment in associates and joint venture 187 150 37 24.49
the study, in case Aukkrarawat has to bear the cost of waste water transportation to the neighboring community, the commercial feasibility of the project would significantly decrease. The reason is
be resulting that the Company would be able to decrease net outstanding debts in the amount of USD 123,899,729 or equivalent to THB 4,275,683,281.33 including the haircut of accrued interest of such
DCORP 050/2019 November 12, 2019 Subject: Report on the overall operation for first 9 months of the year 2019 ended September 30, 2019 and the decrease in the overall operation more than 20 percent
Company started trading its newly issued stock on 15 February 2017. Issued and paid-up share capital Ownership interest 30 June 2017 30 June 2017 Name of the entity Type of business Baht % 80.00 99.27 Car
subsidiaries financial statement for the fiscal year 2014, ended as of December 31, 2014 (Revised Version) which details are as following; Result 2014 (Revised Version) 2013 Increase (Decrease) Million Baht
subsidiaries financial statement for the fiscal year 2015, ended as of December 31, 2015 which details are as following; Results 2015 (Revised Version) 2014 (Revised Version) Increase (Decrease) Million Baht